| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 45 |
| 1 | TACROLIMUS OINTMENT 0.1% | 35 |
| 2 | TACROLIMUS | 34 |
| 3 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 34 |
| 4 | MYCOPHENOLATE MOFETIL | 33 |
| 5 | BORTEZOMIB | 11 |
| 6 | METHOTREXATE SODIUM | 11 |
| 7 | RITUXIMAB | 11 |
| 8 | METHOTREXATE | 10 |
| 9 | SIROLIMUS | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ATRACURIUM BESYLATE | 1 | 0.0014 |
| 1 | DACTINOMYCIN | 2 | 0.0009 |
| 2 | TRABECTEDIN | 2 | 0.0009 |
| 3 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 6 | 0.0007 |
| 4 | SIROLIMUS | 10 | 0.0007 |
| 5 | TALIMOGENE LAHERPAREPVEC | 1 | 0.0006 |
| 6 | CROMOLYN SODIUM | 2 | 0.0005 |
| 7 | VINBLASTINE SULFATE | 1 | 0.0005 |
| 8 | ISOFLURANE | 1 | 0.0005 |
| 9 | AFATINIB | 3 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 2 | 0.0009 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 2 | 0.0003 |
| 2 | Paramagnetic Contrast Agent [EPC] | 1 | 0.0002 |
| 3 | Lipopeptide Antibacterial [EPC] | 1 | 0.0001 |
| 4 | Calcitonin Gene-related Peptide Antagonist [EPC] | 1 | 0.0001 |
| 5 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 6 | Proteasome Inhibitor [EPC] | 11 | 0.0001 |
| 7 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 8 | Melatonin Receptor Agonist [EPC] | 1 | 0.0001 |
| 9 | Alkylating Drug [EPC] | 15 | 0.0001 |